Back to all news

Less than 30% of Radiology AI Devices Undergo Clinical Testing Before FDA Clearance

Less than 30% of Radiology AI Devices Undergo Clinical Testing Before FDA Clearance

A new study finds that under 30% of radiology-focused AI/ML devices authorized by the FDA had clinical testing prior to authorization.

Key Details

  • 1FDA has cleared over 1,000 AI/ML devices, most for radiology.
  • 2Research published in JAMA Network Open reviewed almost 1,000 algorithms approved from 1995 to June 2024.
  • 3Of 723 radiology devices, fewer than 30% underwent any form of clinical testing.
  • 4Very few devices were subject to prospective trials before clearance.
  • 5Authors highlight a lack of standards for safety and efficacy in FDA authorization of AI/ML devices.

Why It Matters

The rapid proliferation of AI/ML devices in radiology without adequate clinical validation raises concerns about patient safety and efficacy. The findings emphasize an urgent need for more rigorous regulatory oversight and defined testing standards for imaging AI tools.
Radiology Business

Source

Radiology Business

View all from this source

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.